AU4308300A - Pyrazoles having antiinflammatory activity - Google Patents

Pyrazoles having antiinflammatory activity

Info

Publication number
AU4308300A
AU4308300A AU43083/00A AU4308300A AU4308300A AU 4308300 A AU4308300 A AU 4308300A AU 43083/00 A AU43083/00 A AU 43083/00A AU 4308300 A AU4308300 A AU 4308300A AU 4308300 A AU4308300 A AU 4308300A
Authority
AU
Australia
Prior art keywords
pyrazoles
antiinflammatory activity
antiinflammatory
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43083/00A
Inventor
Venkateswarlu Akella
Braj Bhushan Lohray
Vidya Bhushan Lohray
Ganapathi Reddy Pamulapati
Misra Parimal
Rajagopalan Ramanujam
Kumar Singh Sunil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Publication of AU4308300A publication Critical patent/AU4308300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
AU43083/00A 1999-05-03 2000-05-02 Pyrazoles having antiinflammatory activity Abandoned AU4308300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN508MA1999 1999-05-03
IN508/MAS/99 1999-05-03
PCT/IB2000/000556 WO2000066562A1 (en) 1999-05-03 2000-05-02 Pyrazoles having antiinflammatory activity

Publications (1)

Publication Number Publication Date
AU4308300A true AU4308300A (en) 2000-11-17

Family

ID=11095418

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43083/00A Abandoned AU4308300A (en) 1999-05-03 2000-05-02 Pyrazoles having antiinflammatory activity

Country Status (2)

Country Link
AU (1) AU4308300A (en)
WO (1) WO2000066562A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74539C2 (en) * 1999-12-08 2006-01-16 Pharmacia Corp Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
SK12682001A3 (en) 1999-12-08 2002-07-02 Pharmacia Corporation, Corporate Patent Department Solid-state form of celecoxib having enhanced bioavailability
ES2166710B1 (en) * 2000-04-25 2004-10-16 J. URIACH & CIA, S.A. NEW HETEROCICLIC COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY.
JP2005500349A (en) * 2001-08-01 2005-01-06 アルタナ　ファルマ　アクチエンゲゼルシャフト Combination of selective COX-2 inhibitor and lung surfactant for respiratory syndrome
US6956052B2 (en) 2001-09-19 2005-10-18 Pharmacia Corporation Substituted pyrazolyl compounds for the treatment of inflammation
WO2003037335A1 (en) * 2001-11-02 2003-05-08 Pfizer Products Inc. 5-heteroatom-substituted pyrazoles
WO2003037330A1 (en) 2001-11-02 2003-05-08 Pfizer Products Inc. Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
US7141678B2 (en) * 2002-05-24 2006-11-28 Pharmacia Corporation Synthesis of diaryl pyrazoles
CA2492066A1 (en) * 2002-06-28 2004-01-08 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
BR0316332A (en) 2002-12-02 2005-09-27 Astellas Pharma Inc Pyrazolic compound, pharmaceutical composition and analgesic agent containing same, process for its preparation and use and commercial package
GB0308318D0 (en) * 2003-04-10 2003-05-14 Merck Sharp & Dohme Therapeutic agents
EP1631568A1 (en) * 2003-04-18 2006-03-08 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
US8247576B2 (en) 2003-12-23 2012-08-21 Astex Therapeutics Limited Pyrazole derivatives as protein kinase modulators
AU2005295753A1 (en) * 2004-10-15 2006-04-27 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
US8343953B2 (en) 2005-06-22 2013-01-01 Astex Therapeutics Limited Pharmaceutical compounds
WO2006136837A2 (en) 2005-06-23 2006-12-28 Astex Therapeutics Limited Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
TWI435874B (en) 2008-10-31 2014-05-01 Toray Industries A cyclohexane derivative and the medical and pharmaceutical use
CA2793709C (en) * 2010-03-31 2017-09-12 Toray Industries, Inc. Therapeutic agent or prophylactic agent for fibromyalgia
MX2012010766A (en) 2010-03-31 2012-10-15 Toray Industries Therapeutic agent or preventive agent for urine collection disorder.
JP5682555B2 (en) * 2010-04-28 2015-03-11 東レ株式会社 Therapeutic or preventive agent for Alzheimer's disease
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
CN114555555B (en) * 2019-10-16 2024-03-01 拜耳公司 Process for preparing 1,1' -disulfanediylbis (4-fluoro-2-methyl-5-nitrobenzene)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792587A (en) * 1971-12-11 1973-06-12 Hoechst Ag AZOIC COLORANTS AND THEIR PREPARATION
DE3420985A1 (en) * 1983-10-15 1985-04-25 Bayer Ag, 5090 Leverkusen SUBSTITUTED 5-ACYLAMINO-1-PHENYLPYRAZOLE
KR100229343B1 (en) * 1993-11-30 1999-11-01 윌리암스 로저 에이 Substituted pyrazolyl benzene sulfoneamides for the treatment of inflammation
IT1287174B1 (en) * 1996-11-15 1998-08-04 Angelini Ricerche Spa PHARMACOLOGICALLY ACTIVE DIARYL-CYCLOMETHYLENPYRAZOLES, PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
TNSN99111A1 (en) * 1998-06-11 2005-11-10 Pfizer NOVEL SULFONYLBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
WO2000066562A1 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
AU4308300A (en) Pyrazoles having antiinflammatory activity
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU6330099A (en) Novel heterocyclyl-methyl-substituted pyrazoles
AU2678800A (en) Modified calycins
AU5967600A (en) Candystraw
AU6335000A (en) Depthimeter
AU4115400A (en) Short-circuiter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2804600A (en) Arylaminoalkylamides
AU2023701A (en) Sketcher
AU2699800A (en) Organoceramics
AU6098300A (en) Follistatin-3
AU4916900A (en) Benzofuranylsulfonates
AU3191100A (en) Ligand-bonded complex
AU4561600A (en) Benzofuranylaminoalcohols
AU1901801A (en) Glucofuranoses
AU4625400A (en) Connecting organ
AU2582200A (en) Windturbine
AU4435300A (en) Hula-hoop
AU7513400A (en) Hydantoin-racemase
AU1915601A (en) Periotome
AU7303400A (en) Osseo-distractor
AU7462200A (en) Loudspeaker

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase